161

Epidemiology & Public Health
Focuses on global human health and epidemic prevention.
Sub Categories on Epidemiology & Public Health
Latest Articles
SARS-CoV-2 hijacks antiviral human proteins to enter human cells

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind
Type 1 IFNs may mediate Zika pregnancy complications

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I
SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator
First-in-human vaccine trial for deadly Nipah virus launched

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t
Bubonic plague kills New Mexico man, officials say: What to know about the 'Black Death'

Bubonic plague kills New Mexico man, officials say: What to know about the 'Black Death'

by Don Sweeney, The Kansas City StarA scanning electron microscope micrograph depicting a mass ofYersinia pestisbacteria in the foregut of an infected flea. Credit: WikipediaA New Mexico m

Bubonic plague kills New Mexico man, officials say: What to know about the 'Black Death'

by Don Sweeney, The Kansas City StarA scanning electron microscope micrograph depicting a mass ofYersinia pestisbacteria in the foregut of an infected flea. Credit: WikipediaA New Mexico m
HIV: An antidiabetic drug to reduce chronic inflammation

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma
Antibody production in patients hospitalized with COVID-19

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV
Learning for life: The higher the level of education, the lower the risk of dying

Learning for life: The higher the level of education, the lower the risk of dying

by Norwegian University of Science and Technology"Effects of education on adult mortality: A global systematic review and meta-analysis" (The Lancet Public Health, 2024) provides the mo

Learning for life: The higher the level of education, the lower the risk of dying

by Norwegian University of Science and Technology"Effects of education on adult mortality: A global systematic review and meta-analysis" (The Lancet Public Health, 2024) provides the mo
Clues to COVID-19 complications come from NET-like inflammatory response

Clues to COVID-19 complications come from NET-like inflammatory response

by University of Utah Health SciencesUniversity of Utah Health critical care specialist Elizabeth Middleton, MD, treats patients with COVID-19 in the intensive care unit. A research team includin

Clues to COVID-19 complications come from NET-like inflammatory response

by University of Utah Health SciencesUniversity of Utah Health critical care specialist Elizabeth Middleton, MD, treats patients with COVID-19 in the intensive care unit. A research team includin
Type-I interferon stops immune system from 'going rogue' during viral infections

Type-I interferon stops immune system from 'going rogue' during viral infections

by McMaster UniversityCredit: CC0 Public DomainMcMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.They ha

Type-I interferon stops immune system from 'going rogue' during viral infections

by McMaster UniversityCredit: CC0 Public DomainMcMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.They ha
Researchers find that anti-HIV drugs may prevent complications from bacterial sepsis

Researchers find that anti-HIV drugs may prevent complications from bacterial sepsis

by Brigham and Women’s HospitalERV expression correlates with abscess susceptibility. (A) Schematic of variation in abscess susceptibility in BALB/cJ, B6J, and B6N female mice. (B) Schematic of R

Researchers find that anti-HIV drugs may prevent complications from bacterial sepsis

by Brigham and Women’s HospitalERV expression correlates with abscess susceptibility. (A) Schematic of variation in abscess susceptibility in BALB/cJ, B6J, and B6N female mice. (B) Schematic of R
Chicago migrant shelter reports measles outbreak

Chicago migrant shelter reports measles outbreak

by Physician's Briefing StaffThe U.S. Centers for Disease Control and Prevention has sent a team to Chicago to help contain an outbreak of measles that has sickened four.The Chicago Department of

Chicago migrant shelter reports measles outbreak

by Physician's Briefing StaffThe U.S. Centers for Disease Control and Prevention has sent a team to Chicago to help contain an outbreak of measles that has sickened four.The Chicago Department of